The Georgetown University Memory Disorders Program is dedicated to providing state-of-the-art clinical services for individuals affected by Alzheimer's disease and related disorders and to conducting research aimed at improving treatment options for Alzheimer's disease.


"Like" our facebook page to stay up to date on research findings and helpful information


Would you like to write an article for our Spring newsletter? Sign up here to share your experiences with the MDP  or to address any issues relevant to those we serve. If you are not interested in composing an article, you are welcome to list topics you would like to see discussed in our next newsletter. Click this link for more.

Research Studies

Here are our research studies that are currently recruiting patients.

Title Sponsor
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss (A4) ADCS/ Eli Lilly and Company

An Efficacy and Safety Trial of MK-8931 in Mild to Moderate Alzheimer's Disease (P07738 AM3) (EPOCH)


DOD-ADNI: A Study of Brain Aging in Vietnam War Veterans


Efficacy and Safety Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease

Elan Pharmaceuticals

Effect of Passive Immunization on the Progression of Mild Alzheimer’s Disease: Solanezumab (LY2062430) versus Placebo

Eli Lilly and Company

Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (NOBLE)

ADCS/Toyama Chemical Co.

Efficacy and Safety Trial of MK-8931 in Participants With Prodromal Alzheimer's Disease (MK-8931-019) (APECS)


Check out our Research section for more information on how to participate in our clinical trials.

Make a Donation

For information about how to make a tax-deductible contribution to the Memory Disorders Program, please click here.